Growth continues for another quarter as market leaders gain more share.

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.

Among the many topics covered in the Q318 Infection Prevention Market Recap are:

All segments showing softness, lowest quarterly growth rate since 2015

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +3.0% YoY, with Acelity, also known as KCI, maintaining its leadership position with estimated Q318 revenues of...

Products that prevent peripheral IV failures could be the next big thing in the market for vascular access adjunct products, a market opportunity valued at more than $600MM in the US alone, according to SmartTRAK estimates.

All eyes were on the high failure rate of peripheral IVs at the Association of Vascular Access (AVA) 2018 Annual Scientific Meeting, with speakers highlighting the 2015 article by Helm et al. “Accepted but Unacceptable: Peripheral IV Catheter Failure,” which estimates a PIV failure rate of 35% to 50% primarily caused by phlebitis, infiltration, occlusion/mechanical failure, dislodgment and infection. Failure is defined as the removal of the catheter prior to the end of its intended life or before the 72 to 96 hours previously used as a guideline. And with up to 90% of all hospitalized patients receiving a PIV, it is a standard but often overlooked procedure in the hospital.

The primary emphasis over the last 10 to 15 years has been the reduction of catheter-related bloodstream infections (CRBSIs) associated with central line catheters. Driving this focus has been CMS reimbursement penalties for hospital acquired central line bloodstream infections (CLABSIs). This new focus on PIVs could be exciting for manufacturers, especially those with adjunct vascular access products. Clinicians insert approximately 250 million PIVs every year in the US (assuming a 25% failure rate on first insertion), a market that is 25 times larger than the US market for central line catheters...

SmartTRAK is excited to be attending SAWC Fall 2018 on November 2-4 at Caesars Palace in Las Vegas.

Susan Paquette, VP & GM Wound, BioMedGPS and Geoffrey Brown, Director Corporate Accounts, Wound Care will be there representing SmartTRAK. Please contact us if you would like to meet. 

Growth continues for all segments during the quarter, led by top 3 players.

For Q218, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY...

Among the many topics covered in detail in the comprehensive Q218 Infection Prevention Market Recap are:

All segments experiencing modest growth of +4% to +5%: advanced dressings recovering, biologics slowing down, and single-use boosting NPWT.

For Q218, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew +4.7% compared to Q217.

Among the many topics covered in detail in the comprehensive Q218 Advanced Wound Care Market Recap are:

BioMedGPS, the leader in online business intelligence for the Medical Device and Life Science industries, is seeking an Advanced Wound Care (AWC) Analyst to support SmartTRAK Business Intelligence, an online, comprehensive, easy-to-use, web-based business intelligence solution used by the top  global wound care manufacturers. SmartTRAK integrates real time market data and analysis accessible throughout an organization, fostering an innovative collaborative approach to market strategy resulting in better decision-making.

We are looking for an experienced, motivated individual with expertise in the AWC market with knowledge of Wound Biologics, External Devices (NPWT), Advanced Dressings and Diagnostic Aids. This individual has worked for a wound care manufacturer, preferably in a marketing or business development role. The position is part-time, 15-20 hours per week.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Infection Prevention Market Recap.

For Q118, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +3.9% YoY. Market gains continue as BD moves into leadership position...

Among the many topics covered in the full Q118 Infection Prevention Market Recap are: 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Advanced Wound Care Market Recap.

Susan Paquette, VP & General Manager Wound at SmartTRAK, was quoted in the press release announcing the 3rd Annual Advanced Wound Care Innovation Award presented to SastoMed GmbH by Alira Health and the European Wound Management Association (EWMA) on May 18, 2018, for their hemoglobin-based wound spray, which can be used easily in everyday wound healing treatment as an adjunct to the current standard of care.